Research Paper Volume 13, Issue 5 pp 7549—7569

Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease

Forest plots of the effect of ginsenoside Rg1 for anti-oxidation. Ginsenoside Rg1 (A) improved the activity of SOD; (B) decreased the level of MDA; (C) improved the activity of GSH; (D) improved the activity of GSH-PX; (E) decreased the level of ROS compared with a control group.

Figure 6. Forest plots of the effect of ginsenoside Rg1 for anti-oxidation. Ginsenoside Rg1 (A) improved the activity of SOD; (B) decreased the level of MDA; (C) improved the activity of GSH; (D) improved the activity of GSH-PX; (E) decreased the level of ROS compared with a control group.